ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,505, issued on Sept. 23, was assigned to Codexis Inc. (Redwood City, Calif.).
"Polynucleotides encoding engineered acetate kinase variant enzymes" was invented by Margie Tabuga Borra-Garske (Palo Alto, Calif.), Oscar Alvizo (Fremont, Calif.), Lillian Jasmine Miller (Saratoga, Calif.) and Aksiniya Lyubenova Petkova (Sunnyvale, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides engineered acetate kinase (AcK) enzymes, polypeptides having AcK activity, and polynucleotides encoding these enzymes, as well as vectors and host cells comprising these polynucleotides and polypeptides. Methods for producing AcK enzymes are a...